Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 208, Issue 7, Pages 1339-1350Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20110551
Keywords
-
Categories
Funding
- National Institute of Allergy and Infectious Disease/National Institutes of Health
Ask authors/readers for more resources
Pulmonary fibrosis is a highly heterogeneous and lethal pathological process with limited therapeutic options. Although research on the pathogenesis of pulmonary fibrosis has frequently focused on the mechanisms that regulate the proliferation, activation, and differentiation of collagen-secreting myofibroblasts, recent studies have identified new pathogenic mechanisms that are critically involved in the initiation and progression of fibrosis in a variety of settings. A more detailed and integrated understanding of the cellular and molecular mechanisms of pulmonary fibrosis could help pave the way for effective therapeutics for this devastating and complex disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available